<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">731741</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2021.731741</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer</article-title>
<alt-title alt-title-type="left-running-head">Zhao et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Immune Effect of Active Components</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Wenjie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1383040/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jinhua</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1452455/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Yaqun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1382942/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chen</surname>
<given-names>Zichao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Qi</surname>
<given-names>Dongmei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Zhen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1288209/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, <addr-line>Jinan</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>College of Chinese Medicine, Shandong University of Traditional Chinese Medicine, <addr-line>Jinan</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Experimental Center, Shandong University of Traditional Chinese Medicine, <addr-line>Jinan</addr-line>, <country>China</country>
</aff>
<author-notes>
<corresp id="c001">&#x2a;Correspondence: Zichao Chen, <email>chenzichao11@126.com</email>; Dongmei Qi, <email>qidm119@163.com</email>; Zhen Zhang, <email>zhangzhen19801981@126.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/561129/overview">Tao Xu</ext-link>, Anhui Medical University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1155712/overview">Guang-Bo Ge</ext-link>, Shanghai University of Traditional Chinese Medicine, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1403794/overview">Lauren Gollahon</ext-link>, Texas Tech University, United&#x20;States</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>731741</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>07</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Zhao, Liu, Li, Chen, Qi and Zhang.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Zhao, Liu, Li, Chen, Qi and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Triple-negative breast cancers are heterogeneous, poorly prognostic, and metastatic malignancies that result in a high risk of death for patients. Targeted therapy for triple-negative breast cancer has been extremely challenging due to the lack of expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. Clinical treatment regimens for triple-negative breast cancer are often based on paclitaxel and platinum drugs, but drug resistance and side effects from the drugs frequently lead to treatment failure, thus requiring the development of new therapeutic platforms. In recent years, research on traditional Chinese medicine in modulating the immune function of the body has shown that it has the potential to be an effective treatment option against triple-negative breast cancer. Active components of herbal medicines such as alkaloids, flavonoids, polyphenols, saponins, and polysaccharides have been shown to inhibit cancer cell proliferation and metastasis by activating inflammatory immune responses and can modulate tumor-related signaling pathways to further inhibit the invasion of triple-negative breast cancer. This paper reviews the immunomodulatory mechanisms of different herbal active ingredients against triple-negative breast cancer and provides an outlook on the challenges and directions of development for the treatment of triple-negative breast cancer with herbal active ingredients.</p>
</abstract>
<kwd-group>
<kwd>triple-negative breast cancer</kwd>
<kwd>traditional Chinese medicine</kwd>
<kwd>herbal remedies active ingredients</kwd>
<kwd>tumor immunity</kwd>
<kwd>anti-tumor</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Breast cancer is a serious threat to women&#x2019;s life and health safety, especially triple-negative breast cancer (TNBC). The main feature of the disease is the lack of expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) (<xref ref-type="bibr" rid="B66">Pareja and Reis-Filho, 2018</xref>). Neither endocrine therapy nor conventional targeted therapy is the best treatment (<xref ref-type="bibr" rid="B25">Goto et&#x20;al., 2018</xref>). Chemotherapy is still the mainstay of advanced TNBC with paclitaxel/anthracycline-containing agents as the chemotherapy of choice, and platinum-based agents in combination with paclitaxel as an effective alternative adjuvant chemotherapy option for patients with operable TNBC (<xref ref-type="bibr" rid="B16">Coates et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B88">Yu et&#x20;al., 2020</xref>). But these drugs were not developed as precise treatments based on the genetic and hereditary characteristics of TNBC itself, although the above regimens have resulted in prolonged survival cycles, the toxic effects are heavy and still not tolerated by some patients (<xref ref-type="bibr" rid="B25">Goto et&#x20;al., 2018</xref>). Without other effective approaches, it may mean a poor prognosis. There is an urgent need to find a new effective anti-TNBC drug with few side effects (<xref ref-type="bibr" rid="B14">Chu et&#x20;al., 2003</xref>).</p>
<p>TNBC is a kind of highly malignant cancer. It&#x2019;s evolution and drug resistance remain the greatest challenges to disease treatment. Since targeted therapies are less effective against TNBC, immunotherapy may benefit patients. Immune-related drug targets are currently used in the clinical treatment of TNBC patients (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>) (<xref ref-type="bibr" rid="B47">Li et&#x20;al., 2018a</xref>). Paul Ehrlich, who first proposed the doctrine of immune surveillance in 1909, suggested that abnormal immune function might contribute to the development of tumors (<xref ref-type="bibr" rid="B21">Ehrlich., 1909</xref>). The first immune detection site to be used in medical practice was cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), discovered in 1987 (<xref ref-type="bibr" rid="B7">Brunet et&#x20;al., 1987</xref>). James Allison&#x2019;s group first demonstrated in experiments in mice that the use of CTLA-4 antibodies could enhance immunity and suppress tumor development in 1996 (<xref ref-type="bibr" rid="B41">Leach et&#x20;al., 1996</xref>). Programmed cell death-1 (PD-1) was discovered in 1992, and studies targeting the immune checkpoints CTLA-4, PD-1, and programmed cell death-Ligand 1 (PD-L1) have led to breakthroughs in a variety of cancer types. PD-1 inhibitors have brought the treatment of malignant tumors into a new era of immunotherapy (<xref ref-type="bibr" rid="B37">Ishida et&#x20;al., 1992</xref>; <xref ref-type="bibr" rid="B92">Zhang et&#x20;al., 2021</xref>). PD-1, in combination with PD-L1, can transmit inhibitory signals and help tumors undergo immune escape. Approximately 20% of TNBC express PD-L1 (<xref ref-type="bibr" rid="B60">Mittendorf et&#x20;al., 2014</xref>), targeting PD-L1 therapy in TNBC patients with positive PD-L1 expression was found to prolong the survival of such patients (<xref ref-type="bibr" rid="B71">Romero, 2019</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>TNBC-related immune drug targets (<xref ref-type="bibr" rid="B46">Li et&#x20;al., 2018</xref>).</p>
</caption>
<graphic xlink:href="fphar-12-731741-g001.tif"/>
</fig>
<p>The database for Traditional Chinese Medicine on Immuno-Oncology contains 400 tumor immune targets from different literature and the corresponding 126,972 ligand molecules, demonstrating the active role of traditional Chinese medicine (TCM) in immune function (<xref ref-type="bibr" rid="B56">Liu et&#x20;al., 2020</xref>). TCM works by modulating immune cells in the body, such as T lymphocytes, bursa dependent lymphocytes, natural killer cells, and macrophages cells, which can exert anti-tumor immune effects (<xref ref-type="bibr" rid="B82">Wang et&#x20;al., 2020</xref>). There are many studies on the combined application of TCM with targeted drugs or immunotherapy, with the main purpose of improving efficacy, reversing drug resistance, reducing adverse effects, and prolonging the survival of patients (<xref ref-type="bibr" rid="B14">Chu et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B53">Liu et&#x20;al., 2019a</xref>). Therefore, this paper focuses on the summary of different active ingredients of TCM in immunotherapy for&#x20;TNBC.</p>
<sec id="s1-1">
<title>Immune Effect of TCM Containing Alkaloids on TNBC</title>
<p>Plant alkaloids play an anti-cancer effect in cancer treatment. By regulating immune function, inhibiting angiogenesis, and inducing cell apoptosis (<xref ref-type="bibr" rid="B20">Efferth and Oesch, 2021</xref>). Tetrandrine has a wide range of antitumor effects and can inhibit MDA-MB-231 cell proliferation and induce cellular autophagy by inhibiting phosphatidylinositol-3-kinase (P13K), protein kinase B (AKT), mammalian target of rapamycin (mTOR) pathway (<xref ref-type="bibr" rid="B52">Liu et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B26">Guo and Pei, 2019</xref>). Reactive oxygen species (ROS) are a class of molecules produced during oxidative stress in the body, which are closely related to tumor immune tolerance and play a key role in immune monitoring (<xref ref-type="bibr" rid="B4">Bailly, 2020</xref>; <xref ref-type="bibr" rid="B33">Hu et&#x20;al., 2021</xref>). ROS-triggered small ubiquitin-like modifier (SUMO)-specific protease 3 accumulation is involved in Treg cell-mediated immunosuppression (<xref ref-type="bibr" rid="B89">Yu et&#x20;al., 2018</xref>). In addition to ROS, activation of the Ras, mitogen-activated protein kinase (MAPK) pathway may promote tumor immune evasion in TNBC (<xref ref-type="bibr" rid="B57">Loi et&#x20;al., 2019</xref>). Sinomenine induced apoptosis in MDA-MB-231 cells by upregulating the MAPK pathway and by increasing intracellular ROS production. It also decreased the expression of IL-8, chemokine receptor 2(CXCR2) in MDA-MB-231 cells. Inhibited the activation of nuclear factor kappa-B (NF-&#x3ba;B) and sonic hedgehog signaling pathways in TNBC lung metastasis. (<xref ref-type="bibr" rid="B44">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B72">Song et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B95">Zhang et&#x20;al., 2019</xref>).</p>
<p>Berberine increased the release of lactate dehydrogenase in MDA-MB-231 cells in a dose-dependent manner, which led to a significant decrease in the secretion of IL-1&#x3b1;, IL-1&#x3b2;, IL-6, and TNF-&#x3b1; at the same time. Synergistic treatment with berberine and lipopolysaccharide significantly reduced the expression of TNF-&#x3b1; and IL- 6 (<xref ref-type="bibr" rid="B98">Zhao et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B39">Kim et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B49">Lin et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B85">Yao et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B85">Yao et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B97">Zhao and Zhang, 2020</xref>). High mobility group box-1(HMGB1) protein is an endogenous member of the proteome called danger-associated molecular pattern that promotes proliferation and survival of a variety of immunosuppressive cells. Synergistic effects of theophylline and berberine induce cell cycle arrest and poly ADP-ribose polymerase (PARP), HMGB1 protein and b-cell lymphoma 2&#x20;family-mediated apoptosis in MDA-MB-231 cells (<xref ref-type="bibr" rid="B83">Wild et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B27">Hashemi-Niasari et&#x20;al., 2018</xref>).</p>
<p>Cisplatin resistance is associated with breast cancer susceptibility genes. The PARP inhibitor olaparib induces CD8<sup>&#x2b;</sup> T&#x20;cell activation <italic>in vivo</italic> (<xref ref-type="bibr" rid="B65">Pantelidou et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B68">Pettitt et&#x20;al., 2020</xref>). Triptolide downregulates PARP1 levels and inhibits BT549 as well as MDA- MB-231 cell growth, mainly by interfering with X-ray repair cross-complement 1, PAPR1-mediated base excision repair, thereby sensitizing TNBC to cisplatin (<xref ref-type="bibr" rid="B96">Zhang et&#x20;al., 2019</xref>). Both Celastrol and Triptolide inhibit mammosphere formation in MDA-MB-231, BT20 progenitor cells. It inhibited the expression of stem cell marker proteins doublecortin-like kinase 1, aldehyde dehydrogenase, and CD133 (Prominin-1) (<xref ref-type="bibr" rid="B69">Ramamoorthy et&#x20;al., 2021</xref>).</p>
<p>In addition to the above TCM containing alkaloids, such as aconitine, betaine, ephedrine, and evodiamine, which also have antitumor effects (<xref ref-type="bibr" rid="B58">Ma and Wink, 2008</xref>; <xref ref-type="bibr" rid="B19">Du et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B36">Hyuga et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B74">Tan et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B93">Zhang et&#x20;al., 2021</xref>), but the immune mechanism of action on TNBC still deserves further investigation.</p>
</sec>
<sec id="s1-2">
<title>Immune Effect of TCM Containing Phenolic Compound on TNBC</title>
<p>During tumor progression, tumor cells continuously interact with the microenvironment and mediate immune tolerance. Polyphenols, the active ingredients of TCM, can inhabit the tumor microenvironment (<xref ref-type="bibr" rid="B35">Hui and Chen, 2015</xref>; <xref ref-type="bibr" rid="B5">Bian et&#x20;al., 2020</xref>). The ability of breast cancer stem cells to self-renew is closely related to disease progression, and high expression of stem cell estrogen receptor alpha-36 (ER-&#x3b1;36) (<xref ref-type="bibr" rid="B18">Deng et&#x20;al., 2014</xref>). Epigallocatechin-3-gallate is a type of catechin extracted from green tea, effectively inhibited the growth of tumor stem, progenitor cells in MDA-MB-231 and MDA-MB-436 cells and reduced the expression of ER-&#x3b1;36 in these cells (<xref ref-type="bibr" rid="B63">Pan et&#x20;al., 2016</xref>). F-Box and WD repeat domain containing 7 (FBXW7) can inhibit tumor development by acting on the tumor microenvironment (<xref ref-type="bibr" rid="B91">Yumimoto et&#x20;al., 2015</xref>). Honokiol downregulates miR-188-5p <italic>via</italic> FBXW7, c-Myc signaling, enhances the sensitivity of human breast cancer to doxorubicin. Honokiol exerts anti-proliferative activity during cell cycle arrest in G0/G1 phase and inhibits the proliferation of MDA-MB-231 cells by suppressing the c-Src, epidermal growth factor receptor (EGFR)-mediated signaling pathway. However, due to the limited oral bioavailability of honokiol, the use of vitamin E polyethylene glycol succinate in nanocapillary formulations enhances the anti-cancer effect of <italic>in situ</italic> TNBC (<xref ref-type="bibr" rid="B67">Park et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B24">Godugu et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B86">Yi et&#x20;al., 2021</xref>). The NF-&#x3ba;B pathway, a key regulator of the immune response, is frequently dysregulated in cancer (<xref ref-type="bibr" rid="B75">Tegowski and Baldwin, 2018</xref>). Magnolol significantly inhibited the activity of highly invasive MDA-MB-231 cells and down-regulated the expression of matrix metallopeptidase 9 (MMP-9), as well as the transcriptional activity of NF-&#x3ba;B and the deoxyribonucleic acid (DNA) binding of NF-&#x3ba;B to the MMP-9 promoter (<xref ref-type="bibr" rid="B55">Liu et&#x20;al., 2013</xref>).</p>
<p>The flavonoids found in TCM have a variety of biological properties, including anti-inflammatory and anti-angiogenic properties, play an immune role by influencing immune organs, cellular immunity, non-specific immunity, and immune-related signal transduction pathways. (<xref ref-type="bibr" rid="B9">Casagrande and Darbon, 2001</xref>; <xref ref-type="bibr" rid="B3">Bagli et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B77">Ullmannova and Popescu, 2007</xref>; <xref ref-type="bibr" rid="B59">Maleki et&#x20;al., 2019</xref>). Puerarin inhibited the migration, invasion and adhesion of lipopolysaccharide-stimulated MDA-MB-231 cells by inhibiting the NF-&#x3ba;B pathway and extracellular regulated protein kinases (ERK) phosphorylation (<xref ref-type="bibr" rid="B54">Liu et&#x20;al., 2017</xref>). However, due to poor water solubility and low bioavailability of puerarin, new puerarin nanoemulsions were developed to induce changes in the immune microenvironment of 4T1 cells, improving the therapeutic efficiency of &#x3b1;-PD-L1 in TNBC models and downregulating intra-tumor ROS (<xref ref-type="bibr" rid="B84">Xu et&#x20;al., 2020</xref>). Licorice flavonoids promote ROS production, increase endogenous and exogenous apoptotic pathways, promote PARP-1 activation in MDA-MB-231 cells, and induce DNA damage. It regulates autophagy and blocks cell growth by inhibiting phosphorylation of AKT and MAPK signaling pathways, regulating the expression of E-cadherin and vimentin (<xref ref-type="bibr" rid="B34">Huang et&#x20;al., 2019</xref>) (-)-Epigallocatechin 3-gallate is a natural polyphenol extracted from green tea, and a series of derivatives were synthesized to improve the pharmacological structure, and all of these compounds were found to exhibit moderate to high cytotoxicity against MDA-MB-231 cells (<xref ref-type="bibr" rid="B17">Crous-Mas&#xf3; et&#x20;al., 2018</xref>).</p>
<p>TCM such as paeonol and curcumin also contain phenolic active ingredients and play an important role in the anti-tumor process (<xref ref-type="bibr" rid="B8">Cai et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B32">Hu et&#x20;al., 2019</xref>), which still need to be further explored in the process of immunotherapy for&#x20;TNBC.</p>
</sec>
<sec id="s1-3">
<title>Immune Effect of Saponins on TNBC</title>
<p>Saponins have pharmacological activities such as antioxidant, anti-inflammatory, and antitumor. The inhibitory effect of ginseng on breast cancer cell growth is mainly through transcriptional upregulation of the cell cycle protein-dependent kinase inhibitors p21 and p53 (<xref ref-type="bibr" rid="B6">Block and Mead, 2003</xref>; <xref ref-type="bibr" rid="B1">AL Shabanah et&#x20;al., 2016</xref>). The combination of ginsenoside panaxatriol with paclitaxel inhibited the activation of interleukin-1 receptor-associated kinase 1(IRAK1), NF-&#x3ba;B and ERK1/2, leading to the inhibition of inflammatory factors, and cancer stem cell-related genes expression was downregulated and also inhibited the invasive ability of MB231-PR (paclitaxel-resistant) cells, reducing stem cell properties and resensitizing TNBC paclitaxel-resistant cells to paclitaxel by inhibiting the IRAK1/NF-&#x3ba;B and ERK pathways (<xref ref-type="bibr" rid="B79">Wang et&#x20;al., 2020</xref>). In contrast, ginsenoside Rg1 induces apoptosis through ROS production and inhibits the development of triple negative breast cancer cells (<xref ref-type="bibr" rid="B15">Chu et&#x20;al., 2020</xref>).</p>
<p>Ginsenoside Rh2 induces apoptosis, reverses abnormal differentiation of tumor cells, and resists tumor metastasis, and can be used in combination with chemotherapeutic drugs to increase the effectiveness and reduce the toxicity. Biochanin A combined with ginsenoside Rh2 has a synergistic effect on the proliferation of MDA-MB-231 and MCF-7 cells (<xref ref-type="bibr" rid="B70">Ren et&#x20;al., 2018</xref>). Ginsenoside Rg3 in combination with paclitaxel treatment inhibited NF-kB activation, decreased NF-kB p65 and B-cell lymphoma-2 (Bcl-2) protein expression, and increased Bcl2-associated X and Caspase-3 protein expression, thus promoting the toxicity of paclitaxel on MDA-MB-231, MDA-MB453, and BT-549 cells (<xref ref-type="bibr" rid="B90">Yuan et&#x20;al., 2017</xref>). After analysis using The Cancer Genome Atlas database identified a role for C-X-C motif chemokine ligand 12 (CXCL12), C-X-C motif chemokine receptor 4 (CXCR4) signaling pathway in oncogenic CD8<sup>&#x2b;</sup> T&#x20;cells from human breast cancer, CXCR4 inhibition could enhance the efficacy of immunotherapy in the treatment of metastatic breast cancer (<xref ref-type="bibr" rid="B10">Chen et&#x20;al., 2019</xref>). At doses without significant cytotoxicity, ginsenoside Rg3 treatment resulted in weaker CXCR4 staining in MDA-MB-231 cells, reduced the number of cells migrating during CXCL12-induced chemotaxis, and significantly reduced the number of CD44&#x20;<sup>high</sup>/CD24&#x20;<sup>low</sup> in MDA-MB-231 cells with therapeutic potential for targeting breast cancer stem cells, possibly through classical mitochondria-dependent caspase activation to induce apoptosis in MDA-MB-231 cells (<xref ref-type="bibr" rid="B11">Chen et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B38">Kim et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B62">Oh et&#x20;al., 2019</xref>).</p>
<p>Murine double minute2 (MDM2) controls the stability of STAT5 in CD8<sup>&#x2b;</sup> T&#x20;cells and targeting p53-MDM2 interactions is essential for effective antitumor immunity. Polyphyllin D can inhibit MDA-MB-231 cell proliferation by decreasing the expression levels of MDM2, murine double minute x, and mutant p53 and inducing cell cycle arrest by upregulating the expression of MDM2 downstream proteins p21 and p27 (<xref ref-type="bibr" rid="B40">Kong et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B99">Zhou et&#x20;al., 2021</xref>). RELT-like protein 2 (Rell2) is a direct target of mircoRNA-18a, and polyphyllin VI increased Rell2 expression and impaired the viability of 4T1 and MDA-MB-231 cells (<xref ref-type="bibr" rid="B81">Wang et&#x20;al., 2019</xref>). Timosaponin AIII, a steroidal saponin, triggers DNA damage in breast cancer, activates the ataxia telangiectasia mutated, cell cycle checkpoint kinase 2 and p38 MAPK pathways, which in turn induces G2/M phase block and MDA-MB-231 apoptosis, and downregulates cell division cycle B1, cell division cycle 2, and cell division cycle 25C. Inhibition of ERK activation through sustained hepatocyte growth factor-induced MDA-MB-231 cell invasion (<xref ref-type="bibr" rid="B76">Tsai et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B94">Zhang et&#x20;al., 2021</xref>). Ophiopogonin D significantly inhibits TNBC cell growth and metastasis <italic>in&#x20;vitro</italic>, mediated in part by inhibition of the integrin subunit beta 1, focal adhesion kinase, Src, AKT, &#x3b2;-catenin signaling pathway (<xref ref-type="bibr" rid="B100">Zhu et&#x20;al., 2020</xref>).</p>
</sec>
<sec id="s1-4">
<title>Immune Effect of Polysaccharides TCM on TNBC</title>
<p>Polysaccharides isolated from TCM have immunomodulatory and antitumor effects and play an important role in immunosuppression (<xref ref-type="bibr" rid="B12">Chen et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B51">Liu et&#x20;al., 2018</xref>). Based on the basis of network-based pharmacology it was determined that astragalus polysaccharide may interfere with the invasion and proliferation of MDA-MB-231 cells by inhibiting PI3KCG/AKT/Bcl2 pathway expression and can promote apoptosis. <italic>In vitro</italic> experiments it confirmed that astragalus polysaccharide inhibits TNBC symptoms in a dose-dependent manner (<xref ref-type="bibr" rid="B50">Liu et&#x20;al., 2019b</xref>). Huaier polysaccharide inhibited the stem cell-like characteristics of MDA-MB-231, MDA-MB-453 and Hs578T&#x20;cells <italic>in&#x20;vitro</italic> and <italic>in vivo</italic>, partly through the estrogen receptor &#x3b1;-36 signaling pathway (<xref ref-type="bibr" rid="B31">Hu et&#x20;al., 2019</xref>). Fucoidan inhibits MAPK and P13K activation, suppresses activating protein-1 and NF-&#x3ba;B signaling, downregulates pro-angiogenic factor expression in TNBC cells, exhibits anti-ataxia telangiectasia mutated, cell cycle checkpoint kinase 2 proliferative activity against MDA-MB-231 and HCC1806 cells, and effectively reduces migration and invasion (<xref ref-type="bibr" rid="B29">Hsu et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B30">Hsu et&#x20;al., 2020</xref>). Cordyceps polysaccharides effectively inhibited MDA-MB-231 cell metastasis and restored drug sensitivity in topotecan-resistant cells by downregulating the transforming growth factor-&#x3b2; signaling pathway and EMT program (<xref ref-type="bibr" rid="B48">Lin et&#x20;al., 2016</xref>).</p>
<p>Shiitake mushroom polysaccharide, Ganoderma lucidum polysaccharide, polysaccharides from the roots of platycodon grandiflorum, Safflower polysaccharide and Ginseng polysaccharide all have strong anti-tumor activity (<xref ref-type="bibr" rid="B13">Chihara et&#x20;al., 1969</xref>; <xref ref-type="bibr" rid="B2">Ando et&#x20;al., 2002</xref>; <xref ref-type="bibr" rid="B23">Gao et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B87">Yoon et&#x20;al., 2003</xref>). However, studies in TNBC are still relatively few and the immune mechanism of action is unclear, which deserves further development.</p>
</sec>
<sec id="s1-5">
<title>Immune Effect of Other TCM Ingredients on TNBC</title>
<p>In addition to the aforementioned drugs, tubeimu also exhibited <italic>in&#x20;vitro</italic> inhibition of TNBC cell migration and invasion without significant toxic side effects (<xref ref-type="bibr" rid="B78">Wang et&#x20;al., 2018</xref>). Cantharidin reverses the metastasis of MDA-MB-231 cells by inhibiting pyruvate kinase isozyme type M2 nuclear translocation and disrupting the glucose transporter 1, pyruvate kinase isozyme type M2 glycolytic cycle, leading to the conversion of aerobic glycolysis to oxidation (<xref ref-type="bibr" rid="B64">Pan et&#x20;al., 2019</xref>). More toxic drugs may limit their use <italic>in vivo</italic> and improve <italic>in vivo</italic> safety by developing a novel drug, &#x3b1;<bold>-</bold>amanitin-conjugated trastuzumab, which kills tumor cells while inducing immunogenic cell death, using the HER2 antibody trastuzumab coupled to &#x3b1;<bold>-</bold>amanitin, and cells containing 17p deletion, which are expressed at low levels of HER2 (<xref ref-type="bibr" rid="B45">Li et&#x20;al., 2021</xref>). Bufalin increased the expression of necrosis mediators threonine kinase1 and threonine kinase3, induced MDA-MB-231 cell death and inhibited the growth of both human breast cancer MCF-7 and MDA-MB-231 cells through the reactive oxygen species-mediated RIP1/RIP3/PARP-1 pathway (<xref ref-type="bibr" rid="B46">Li et&#x20;al., 2018b</xref>).</p>
<p>Arctigenin induces prolonged p21 expression and p38-mediated apoptosis-inducing factor-dependent cell death, which enhanced the toxicity of adriamycin in human breast cancer cells. (<xref ref-type="bibr" rid="B42">Lee et&#x20;al., 2020</xref>). Three triterpenes were isolated from cactus, of which compound d2 was identified as betulinic acid, and treatment of MDA-MB-231 cells with betulinic acid-rich cactus resulted in activation of c-Jun N-terminal kinase as well as downregulation of ERK1 (<xref ref-type="bibr" rid="B22">Foo et&#x20;al., 2016</xref>). Citrus hystrix DC extract and its compounds citronellol and citronellal induce apoptosis in MDA-MB-231 by inhibiting the anti-apoptotic protein Bcl-2, leading to activation of the pro-apoptotic Bcl2-associated X protein and inducing a downstream cystatin-dependent apoptotic pathway by activating cystatin-3 protein (<xref ref-type="bibr" rid="B28">Ho et&#x20;al., 2020</xref>). Rhubarb acid derivatives are new anthraquinones that downregulate Rac1 expression and maybe small molecule inhibitors of Rac1 (<xref ref-type="bibr" rid="B43">Li et&#x20;al., 2020</xref>). Gambogic acid significantly inhibits viability and increases apoptosis of paclitaxel-resistant MDA-MB-231 cells through activation of the sonic hedgehog signaling pathway (<xref ref-type="bibr" rid="B81">Wang et&#x20;al., 2019</xref>). In a word, we have summarized some key ingredients from the above in <xref ref-type="table" rid="T1">table&#x20;1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Role of TCM in TNBC.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Compound</th>
<th align="center">Detailed activity/mechanism of action</th>
<th align="center">Application</th>
<th align="center">References</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="2" align="left">Sinomenine</td>
<td align="left">Reduced human IL-8 mRNA expression in MDA-MB-231 cells; downregulated CXCR1.</td>
<td align="left">
<italic>In vivo</italic> and <italic>in&#x20;vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B95">Zhang et&#x20;al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">ROS-dependent and non-dependent pathways; upregulated the expression of MAPKs.</td>
<td valign="top" align="left">
<italic>In vivo</italic> and <italic>in&#x20;vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B44">Li et&#x20;al. (2014)</xref>
</td>
</tr>
<tr>
<td align="left">Berberine</td>
<td valign="top" align="left">Inhibited IL-1&#x3b1;, IL-1&#x3b2;, IL-6, TNF-&#x3b1; expression; downregulated EGFR protein expression</td>
<td align="left">
<italic>In vivo</italic> and <italic>in&#x20;vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B97">Zhao and Zhang, (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Theophylline</td>
<td valign="top" align="left">Reduced extracellular levels of HMGB1 protein and downregulated HMGB1 and MMP-9 mRNA expression</td>
<td align="left">
<italic>In vitro</italic>
</td>
<td align="left">(<xref ref-type="bibr" rid="B83">Wild et&#x20;al., 2012</xref>, <xref ref-type="bibr" rid="B27">Hashemi-Niasari et&#x20;al. (2018)</xref>
</td>
</tr>
<tr>
<td rowspan="3" align="left">Honokiol</td>
<td valign="top" align="left">Sensitized doxorubicin-resistant breast cancer cells to doxorubicin-induced apoptosis</td>
<td align="left">
<italic>In vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B86">Yi et&#x20;al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">Increased solubility of honokiol in nano-micellar formulations</td>
<td valign="top" align="left">
<italic>In vitro</italic> and <italic>in vivo</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B24">Godugu et&#x20;al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left">Downregulated the expression and phosphorylation of c-Src, EGFR and AKT; inactivated mTOR and its downstream signal molecules</td>
<td valign="top" align="left">
<italic>In vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B67">Park et&#x20;al. (2009)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="left">Puerarin</td>
<td valign="top" align="left">Abrogated the NF-&#x3ba;B; inhibited phosphorylation of p65 and IkB&#x3b1;</td>
<td align="left">
<italic>In vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B54">Liu et&#x20;al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left">Downregulated ROS production in the activated myofibroblast</td>
<td valign="top" align="left">
<italic>In vivo</italic> and <italic>in&#x20;vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B84">Xu et&#x20;al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Licorice flavonoids</td>
<td valign="top" align="left">Reduced MAPK and AKT signaling, suppressed MDA-MB-231 cell migration and invasion</td>
<td align="left">
<italic>In vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B34">Huang et&#x20;al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">(-)-Epigallocatechin 3-gallate</td>
<td valign="top" align="left">Reduced the expression of ER-a36 in MDA-MB-231 and MDA-MB-436 cells</td>
<td align="left">&#x2014;</td>
<td align="left">
<xref ref-type="bibr" rid="B63">Pan et&#x20;al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">Huaier polysaccharide</td>
<td valign="top" align="left">Reduced ER&#x3b1;-36 experssion; attenuatted ER&#x3b1;-36-mediated activation of ER&#x3b2;/&#x3b1;-catenin signaling</td>
<td align="left">
<italic>In vivo</italic> and <italic>in&#x20;vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B32">Hu et&#x20;al. (2019)</xref>
</td>
</tr>
<tr>
<td align="left">Ginsenoside panaxatriol</td>
<td valign="top" align="left">Resensitized TNBC paclitaxel resistant cells to pentatonix by inhibiting the IRAK1/NF-&#x3ba;B and ERK pathways</td>
<td align="left">
<italic>In vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B82">Wang et&#x20;al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Ginsenoside Rh2</td>
<td valign="top" align="left">Upregulated p-p53, p-p38, and phospho-ASK1 proteins, downregulated levels of TNF receptor associated factor 2</td>
<td align="left">
<italic>In vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B70">Ren et&#x20;al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">Ginsenoside Rg3</td>
<td valign="top" align="left">Regulated Bax/Bcl-2 expression on TNBC by inhibited NF-kB signaling</td>
<td align="left">
<italic>In vivo</italic> and <italic>in&#x20;vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B90">Yuan et&#x20;al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left">Polyphyllin VI</td>
<td valign="top" align="left">Inhibited the metastatic potential of 4T1 and MDA-MB-231 cells; attenuated the migration of miR-18a mimic or Rell2&#x20;siRNA-enhanced MDA-MB-231 cells</td>
<td align="left">
<italic>In vivo</italic> and <italic>in&#x20;vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B80">Wang et&#x20;al. (2019)</xref>
</td>
</tr>
<tr>
<td rowspan="2" align="left">Timosaponin AIII</td>
<td valign="top" align="left">Activated ATM/Chk2 and p38 pathways upregulated phospho-histone H2A.X and p-p38 levels</td>
<td align="left">
<italic>In vivo</italic> and <italic>in&#x20;vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B93">Zhang et&#x20;al. (2021)</xref>
</td>
</tr>
<tr>
<td align="left">Inhibited the activation of cytosolic activated transcription factor 2; downregulated cyclo-oxygenase-2 and MMP-9 transcription</td>
<td valign="top" align="left">
<italic>In vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B76">Tsai et&#x20;al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">Fucoidan</td>
<td valign="top" align="left">Inhibited TNBC invasiveness and pro-angiogenesis; regulated EMT by modulated TGFR/Smad dependent signaling</td>
<td align="left">&#x2014;</td>
<td align="left">
<xref ref-type="bibr" rid="B30">Hsu et&#x20;al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Cordyceps polysaccharides</td>
<td valign="top" align="left">Inhibited breast cancer metastasis and restored drug sensitivity in drug-resistant cells by down-regulating the transforming growth factor-&#x3b2; signaling pathway and EMT program</td>
<td align="left">
<italic>In vivo</italic> and <italic>in&#x20;vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B48">Lin et&#x20;al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">Bufalin</td>
<td valign="top" align="left">Inhibited human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways</td>
<td align="left">
<italic>In vivo</italic> and <italic>in&#x20;vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B46">Li et&#x20;al. (2018)</xref>
</td>
</tr>
<tr>
<td align="left">Arctigenin</td>
<td valign="top" align="left">Enhanced DOX-induced DNA damage, decreased the phosphorylation of signal STAT3 and the expressions of RAD51 and survivin</td>
<td align="left">
<italic>In vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B42">Lee et&#x20;al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Exaction of Citrus&#xa0;hystrix DC (Citronellol and Citronellal)</td>
<td valign="top" align="left">Induced apoptosis in MDA-MB-231 cells through inhibition of anti-apoptotic Bcl-2 expression, leading to activation of the caspase-3-dependent pathway</td>
<td align="left">
<italic>In vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B28">Ho et&#x20;al. (2020)</xref>
</td>
</tr>
<tr>
<td align="left">Rhubarb acid derivatives</td>
<td valign="top" align="left">Induced apoptosis, G2/M phase cell cycle arrest and oxidative stress in MDA-MB231 cells; activated pro-apoptotic JNK1; downregulated anti-apoptotic ERK1 and anti-apoptotic bcl-2; increased the bax/bcl-2 ratio and initiated the mitochondrial apoptosis pathway</td>
<td align="left">
<italic>In vitro</italic>
</td>
<td align="left">
<xref ref-type="bibr" rid="B43">Li et&#x20;al. (2020)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec sec-type="conclusion" id="s2">
<title>Conclusion</title>
<p>TCM is widely used as an adjunct method in tumor treatment. Numerous studies have demonstrated that TCM exerts its immune effects through the following pathways, enhanced immune response, reduced immune tolerance, and suppressed tumor immunity. In addition to regulating tumor microenvironment-related factors, such as interleukins, interferons, tumor necrosis factors, chemokines, and growth factors, TCM treatments can also regulate immune cells by restoring the antigen expression function of dendritic cells, enhancement of natural killer cell activity, and inhibition of associated fibroblasts (<xref ref-type="bibr" rid="B73">Takei et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B61">Mu et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B79">Wang et&#x20;al., 2020</xref>). The above study provides a new therapeutic option for TCM immunotherapy against&#x20;TNBC.</p>
<p>This paper mainly reviews the immunomodulatory mechanism of different active ingredients of TCM on TNBC. But research on the effects of TCM on immune responses to TNBC is rather scarce. TCM immunomodulatory effects are less studied and there is little information on immune targets. The majority of the studies are focused on immune factor expression. In TCM treatments with demonstrated toxic side effects, exploring how these can be reduced while increasing immune activation against tumors, is worth further investigation. The mechanisms of TCM synergistic radiotherapy drugs on TNBC are still unclear, and the synergistic immune mechanism of multiple drugs still needs to be explored.</p>
</sec>
</body>
<back>
<sec id="s3">
<title>Author Contributions</title>
<p>WZ prepared the manuscript. WZ and ZZ worked together on the idea, ZZ reviewed the draft and provided important information, YL and JL reviewed the draft, and ZC and DQ reviewed the draft. All authors approved the final version of this manuscript for submission.</p>
</sec>
<sec id="s4">
<title>Funding</title>
<p>This work was supported by the National Nature Science Foundation of China (No. 21775061,81974555), Shandong Provincial Key Research and Development Program (2019GSF108253), Open Funds of State Key Laboratory of ChemoBiosensing and Chemometrics (2019016), Science Foundation of Innovative Research Teams of Accurate Disease Identification and Targeted Therapy (22202105). Details of all funding sources should be provided, including grant numbers if applicable.</p>
</sec>
<sec sec-type="COI-statement" id="s5">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s6">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Shabanah</surname>
<given-names>O. A.</given-names>
</name>
<name>
<surname>Alotaibi</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Al Rejaie</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Alhoshani</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Almutairi</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Alshammari</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Hafez MM. Inhibitory Effect of Ginseng on Breast Cancer Cell Line Growth via Up-Regulation of Cyclin Dependent Kinase Inhibitor, P21 and P53</article-title>. <source>Asian Pac. J.&#x20;Cancer Prev.</source> <volume>17</volume> (<issue>11</issue>), <fpage>4965</fpage>&#x2013;<lpage>4971</lpage>. <pub-id pub-id-type="doi">10.22034/APJCP.2016.17.11.4965</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ando</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tsukumo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wakabayashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Akashi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kataoka</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Safflower Polysaccharides Activate the Transcription Factor NF-Kappa B via Toll-like Receptor 4 and Induce Cytokine Production by Macrophages</article-title>. <source>Int. Immunopharmacol</source> <volume>2</volume> (<issue>8</issue>), <fpage>1155</fpage>&#x2013;<lpage>1162</lpage>. <pub-id pub-id-type="doi">10.1016/s1567-5769(02)00076-0</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stefaniotou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morbidelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ziche</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Psillas</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Luteolin Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis; Inhibition of Endothelial Cell Survival and Proliferation by Targeting Phosphatidylinositol 3&#x27;-kinase Activity</article-title>. <source>Cancer Res.</source> <volume>64</volume> (<issue>21</issue>), <fpage>7936</fpage>&#x2013;<lpage>7946</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-03-3104</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailly</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Regulation of PD-L1 Expression on Cancer Cells with ROS-Modulating Drugs</article-title>. <source>Life Sci.</source> <volume>246</volume>, <fpage>117403</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2020.117403</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Natural Polyphenols Targeting Senescence: A Novel Prevention and Therapy Strategy for Cancer</article-title>. <source>Int. J.&#x20;Mol. Sci.</source> <volume>21</volume> (<issue>2</issue>), <fpage>684</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21020684</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Block</surname>
<given-names>K. I.</given-names>
</name>
<name>
<surname>Mead</surname>
<given-names>M. N.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Immune System Effects of Echinacea, Ginseng, and astragalus: a Review</article-title>. <source>Integr. Cancer Ther.</source> <volume>2</volume> (<issue>3</issue>), <fpage>247</fpage>&#x2013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1177/1534735403256419</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunet</surname>
<given-names>J.&#x20;F.</given-names>
</name>
<name>
<surname>Denizot</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Luciani</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Roux-Dosseto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Suzan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mattei</surname>
<given-names>M. G.</given-names>
</name>
<etal/>
</person-group> (<year>1987</year>). <article-title>A New Member of the Immunoglobulin Superfamily--CTLA-4</article-title>. <source>Nature</source> <volume>328</volume> (<issue>6127</issue>), <fpage>267</fpage>&#x2013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1038/328267a0</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Paeonol Reverses Paclitaxel Resistance in Human Breast Cancer Cells by Regulating the Expression of Transgelin 2</article-title>. <source>Phytomedicine</source> <volume>21</volume> (<issue>7</issue>), <fpage>984</fpage>&#x2013;<lpage>991</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2014.02.012</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casagrande</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Darbon</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Effects of Structurally Related Flavonoids on Cell Cycle Progression of Human Melanoma Cells: Regulation of Cyclin-dependent Kinases CDK2 and CDK1</article-title>. <source>Biochem. Pharmacol.</source> <volume>61</volume> (<issue>10</issue>), <fpage>1205</fpage>&#x2013;<lpage>1215</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-2952(01)00583-4</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>I. X.</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>V. P.</given-names>
</name>
<name>
<surname>Posada</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Adstamongkonkul</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Blocking CXCR4 Alleviates Desmoplasia, Increases T-Lymphocyte Infiltration, and Improves Immunotherapy in Metastatic Breast Cancer</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>116</volume> (<issue>10</issue>), <fpage>4558</fpage>&#x2013;<lpage>4566</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1815515116</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X. P.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.&#x20;H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Ginsenoside Rg3 Inhibits CXCR4 Expression and Related Migrations in a Breast Cancer Cell Line</article-title>. <source>Int. J.&#x20;Clin. Oncol.</source> <volume>16</volume> (<issue>5</issue>), <fpage>519</fpage>&#x2013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1007/s10147-011-0222-6</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>O. M.</given-names>
</name>
<name>
<surname>Oppenheim</surname>
<given-names>J.&#x20;J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Dendritic Cells as a Pharmacological Target of Traditional Chinese Medicine</article-title>. <source>Cell Mol Immunol</source> <volume>3</volume> (<issue>6</issue>), <fpage>401</fpage>&#x2013;<lpage>410</lpage>. </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chihara</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hamuro</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fukuoka</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>1969</year>). <article-title>Inhibition of Mouse Sarcoma 180 by Polysaccharides from Lentinus Edodes (Berk.) Sing</article-title>. <source>Nature</source> <volume>222</volume> (<issue>5194</issue>), <fpage>687</fpage>&#x2013;<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1038/222687a0</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Lamar</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>H. P.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Racial Disparities in Breast Carcinoma Survival Rates: Seperating Factors that Affect Diagnosis from Factors that Affect Treatment</article-title>. <source>Cancer</source> <volume>97</volume> (<issue>11</issue>), <fpage>2853</fpage>&#x2013;<lpage>2860</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.11411</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kanimozhi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brindha</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Ginsenoside Rg1 Induces Apoptotic Cell Death in Triple-Negative Breast Cancer Cell Lines and Prevents Carcinogen-Induced Breast Tumorigenesis in Sprague Dawley Rats</article-title>. <source>Evid. Based Complement. Alternat Med.</source> <volume>2020</volume>, <fpage>8886955</fpage>. <pub-id pub-id-type="doi">10.1155/2020/8886955</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coates</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Winer</surname>
<given-names>E. P.</given-names>
</name>
<name>
<surname>Goldhirsch</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gelber</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Gnant</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Piccart-Gebhart</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Tailoring Therapies-Iimproving the Management of Early Breast Cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015</article-title>. <source>Ann. Oncol.</source> <volume>26</volume> (<issue>8</issue>), <fpage>1533</fpage>&#x2013;<lpage>1546</lpage>. <pub-id pub-id-type="doi">10.1093/annonc/mdv221</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crous-Mas&#xf3;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Palomeras</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Relat</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cam&#xf3;</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Garza</surname>
<given-names>&#xda;.</given-names>
</name>
<name>
<surname>Planas</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>(-)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer</article-title>. <source>Molecules</source> <volume>23</volume> (<issue>5</issue>), <fpage>1160</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23051160</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z. Y.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>ER-&#x3b1;36-mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/progenitor Cells</article-title>. <source>PLoS One</source> <volume>9</volume> (<issue>2</issue>), <fpage>e88034</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0088034</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. F.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q. M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Evodiamine Induces Apoptosis and Inhibits Metastasis in MDA-MB-231 Human Breast Cancer Cells <italic>In Vitro</italic> and <italic>In Vivo</italic>
</article-title>. <source>Oncol. Rep.</source> <volume>30</volume> (<issue>2</issue>), <fpage>685</fpage>&#x2013;<lpage>694</lpage>. <pub-id pub-id-type="doi">10.3892/or.2013.2498</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Efferth</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Oesch</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Repurposing of Plant Alkaloids for Cancer Therapy: Pharmacology and Toxicology</article-title>. <source>Semin. Cancer Biol.</source> <volume>68</volume>, <fpage>143</fpage>&#x2013;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2019</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehrlich</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1909</year>). <article-title>Ueber den jetzigen stand der Karzinomforschung</article-title>. <source>Ned.Tijdschr</source> <volume>5</volume>, <fpage>273</fpage>&#x2013;<lpage>290</lpage>. </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foo</surname>
<given-names>J.&#x20;B.</given-names>
</name>
<name>
<surname>Saiful Yazan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tor</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Wibowo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Armania</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>
<italic>Dillenia suffruticosa</italic> Dichloromethane Root Extract Induced Apoptosis towards MDA-MB-231&#x20;Triple-Negative Breast Cancer Cells</article-title>. <source>J.&#x20;Ethnopharmacol</source> <volume>187</volume>, <fpage>195</fpage>&#x2013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2016.04.048</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Effects of Ganopoly (A Ganoderma Lucidum Polysaccharide Extract) on the Immune Functions in Advanced-Stage Cancer Patients</article-title>. <source>Immunol. Invest.</source> <volume>32</volume> (<issue>3</issue>), <fpage>201</fpage>&#x2013;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1081/imm-120022979</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godugu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Doddapaneni</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Honokiol Nanomicellar Formulation Produced Increased Oral Bioavailability and Anticancer Effects in Triple Negative Breast Cancer (TNBC)</article-title>. <source>Colloids Surf. B Biointerfaces</source> <volume>153</volume>, <fpage>208</fpage>&#x2013;<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2017.01.038</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goto</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kashiwagi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Asano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Significance of Intrinsic Breast Cancer Subtypes on the Long-Term Prognosis after Neoadjuvant Chemotherapy</article-title>. <source>J.&#x20;Transl Med.</source> <volume>16</volume> (<issue>1</issue>), <fpage>307</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-018-1679-0</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Tetrandrine-Induced Autophagy in MDA-MB-231&#x20;Triple-Negative Breast Cancer Cell through the Inhibition of PI3K/AKT/mTOR Signaling</article-title>. <source>Evid. Based Complement. Alternat Med.</source>, <fpage>7517431</fpage>. <pub-id pub-id-type="doi">10.1155/2019/7517431</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashemi-Niasari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rabbani-Chadegani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Razmi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fallah</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Synergy of Theophylline Reduces Necrotic Effect of Berberine, Induces Cell Cycle Arrest and PARP, HMGB1, Bcl-2 Family Mediated Apoptosis in MDA-MB-231 Breast Cancer Cells</article-title>. <source>Biomed. Pharmacother.</source> <volume>106</volume>, <fpage>858</fpage>&#x2013;<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2018.07.019</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Suphrom</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Daowtak</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Potup</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Thongsri</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Usuwanthim</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Anticancer Effect of Citrus hystrix DC. Leaf Extract and its Bioactive Constituents Citronellol and, Citronellal on the Triple Negative Breast Cancer MDA-MB-231 Cell Line</article-title>. <source>Pharmaceuticals (Basel)</source> <volume>13</volume> (<issue>12</issue>), <fpage>476</fpage>. <pub-id pub-id-type="doi">10.3390/ph13120476</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>T. Y.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Tsao</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Fucoidan Induces Changes in the Epithelial to Mesenchymal Transition and Decreases Metastasis by Enhancing Ubiquitin-dependent TGF&#x3b2; Receptor Degradation in Breast Cancer</article-title>. <source>Carcinogenesis</source> <volume>34</volume> (<issue>4</issue>), <fpage>874</fpage>&#x2013;<lpage>884</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgs396</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Mi</surname>
<given-names>F. L.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C. H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Fucoidan from Laminaria Japonica Exerts Antitumor Effects on Angiogenesis and Micrometastasis in Triple-Negative Breast Cancer Cells</article-title>. <source>Int. J.&#x20;Biol. Macromol</source> <volume>149</volume>, <fpage>600</fpage>&#x2013;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.01.256</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Huaier Polysaccharide Inhibits the Stem-like Characteristics of ER&#x3b1;-36high Triple Negative Breast Cancer Cells via Inactivation of the ER&#x3b1;-36 Signaling Pathway</article-title>. <source>Int. J.&#x20;Biol. Sci.</source> <volume>15</volume> (<issue>7</issue>), <fpage>1358</fpage>&#x2013;<lpage>1367</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.27360</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Anti-metastasis Activity of Curcumin against Breast Cancer via the Inhibition of Stem Cell-like Properties and EMT</article-title>. <source>Phytomedicine</source> <volume>58</volume>, <fpage>152740</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2018.11.001</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>SENP3 Senses Oxidative Stress to Facilitate STING-dependent Dendritic Cell Antitumor Function</article-title>. <source>Mol. Cel</source> <volume>81</volume> (<issue>5</issue>), <fpage>940</fpage>&#x2013;<lpage>952</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2020.12.024</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>L. W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Liou</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Licochalcone A Inhibits Cellular Motility by Suppressing E-Cadherin and MAPK Signaling in Breast Cancer</article-title>. <source>Cells</source> <volume>8</volume> (<issue>3</issue>), <fpage>218</fpage>. <pub-id pub-id-type="doi">10.3390/cells8030218</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hui</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Tumor Microenvironment: Sanctuary of the Devil</article-title>. <source>Cancer Lett.</source> <volume>368</volume> (<issue>1</issue>), <fpage>7</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2015.07.039</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyuga</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hyuga</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yoshimura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Amakura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Goda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hanawa</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Herbacetin, a Constituent of Ephedrae Herba, Suppresses the HGF-Induced Motility of Human Breast Cancer MDA-MB-231 Cells by Inhibiting C-Met and Akt Phosphorylation</article-title>. <source>Planta Med.</source> <volume>79</volume> (<issue>16</issue>), <fpage>1525</fpage>&#x2013;<lpage>1530</lpage>. <pub-id pub-id-type="doi">10.1055/s-0033-1350899</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Agata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shibahara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Honjo</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Induced Expression of PD-1, a Novel Member of the Immunoglobulin Gene Superfamily, upon Programmed Cell Death</article-title>. <source>EMBO J.</source> <volume>11</volume> (<issue>11</issue>), <fpage>3887</fpage>&#x2013;<lpage>3895</lpage>. </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>H. K.</given-names>
</name>
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Ginsenoside Rg3 Induces Apoptosis of Human Breast Cancer (MDA-MB-231) Cells</article-title>. <source>J.&#x20;Cancer Prev.</source> <volume>18</volume> (<issue>2</issue>), <fpage>177</fpage>&#x2013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.15430/jcp.2013.18.2.177</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>S. J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Berberine Down-Regulates IL-8 Expression through Inhibition of the EGFR/MEK/ERK Pathway in Triple-Negative Breast Cancer Cells</article-title>. <source>Phytomedicine</source> <volume>50</volume>, <fpage>43</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z. L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Platycodin D, a Metabolite of Platycodin Grandiflorum, Inhibits Highly Metastatic MDA-MB-231 Breast Cancer Growth <italic>In Vitro</italic> and <italic>In Vivo</italic> by Targeting the MDM2 Oncogene</article-title>. <source>Oncol. Rep.</source> <volume>36</volume> (<issue>3</issue>), <fpage>1447</fpage>&#x2013;<lpage>1456</lpage>. <pub-id pub-id-type="doi">10.3892/or.2016.4935</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leach</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Krummel</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Allison</surname>
<given-names>J.&#x20;P.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Enhancement of Antitumor Immunity by CTLA-4 Blockade</article-title>. <source>Science</source> <volume>271</volume> (<issue>5256</issue>), <fpage>1734</fpage>&#x2013;<lpage>1736</lpage>. <pub-id pub-id-type="doi">10.1126/science.271.5256.1734</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>K. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells</article-title>. <source>Int. J.&#x20;Mol. Sci.</source> <volume>21</volume> (<issue>8</issue>), <fpage>2997</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21082997</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Rhein Derivative 4F Inhibits the Malignant Phenotype of Breast Cancer by Downregulating Rac1 Protein</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>754</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.00754</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H. M.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>MAPK Signaling Mediates Sinomenine Hydrochloride-Induced Human Breast Cancer Cell Death via Both Reactive Oxygen Species-dependent and -independent Pathways: an <italic>In Vitro</italic> and <italic>In Vivo</italic> Study</article-title>. <source>Cell Death Dis</source> <volume>5</volume> (<issue>7</issue>), <fpage>e1356</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2014.321</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kulke</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hechler</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Van der Jeught</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Targeted Immunotherapy for HER2-Low Breast Cancer with 17p Loss</article-title>. <source>Sci. Transl Med.</source> <volume>13</volume> (<issue>580</issue>), <fpage>eabc6894</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.abc6894</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2018b</year>). <article-title>Bufalin Inhibits Human Breast Cancer Tumorigenesis by Inducing Cell Death through the ROS-Mediated RIP1/RIP3/PARP-1 Pathways</article-title>. <source>Carcinogenesis</source> <volume>39</volume> (<issue>5</issue>), <fpage>700</fpage>&#x2013;<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgy039</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018a</year>). <article-title>Immunotherapeutic Interventions of Triple Negative Breast Cancer</article-title>. <source>J.&#x20;Transl Med.</source> <volume>16</volume> (<issue>1</issue>), <fpage>147</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-018-1514-7</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lyu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>MHP-1 Inhibits Cancer Metastasis and Restores Topotecan Sensitivity via Regulating Epithelial-Mesenchymal Transition and TGF-&#x3b2; Signaling in Human Breast Cancer Cells</article-title>. <source>Phytomedicine</source> <volume>1523</volume> (<issue>10</issue>), <fpage>1053</fpage>&#x2013;<lpage>1063</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2016.06.013</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>Y. C.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.&#x20;Y.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>L. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Different Mechanisms Involved in the Berberine-Induced Antiproliferation Effects in Triple-Negative Breast Cancer Cell Lines</article-title>. <source>J.&#x20;Cel Biochem</source> <volume>120</volume> (<issue>8</issue>), <fpage>13531</fpage>&#x2013;<lpage>13544</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.28628</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2019b</year>). <article-title>The Modulatory Properties of Astragalus Membranaceus Treatment on Triple-Negative Breast Cancer, an Integrated Pharmacological Method</article-title>. <source>Front. Pharmacol.</source> <volume>10</volume>, <fpage>1171</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2019.01171</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Characterization and Protective Effect of Polygonatum Sibiricum Polysaccharide against Cyclophosphamide-Induced Immunosuppression in Balb/c Mice</article-title>. <source>Int. J.&#x20;Biol. Macromol</source> <volume>107</volume> (<issue>Pt A</issue>), <fpage>796</fpage>&#x2013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.09.051</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Tetrandrine, a Chinese Plant-Derived Alkaloid, Is a Potential Candidate for Cancer Chemotherapy</article-title>. <source>Oncotarget</source> <volume>7</volume> (<issue>26</issue>), <fpage>40800</fpage>&#x2013;<lpage>40815</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.8315</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2019a</year>). <article-title>Effects of Adjuvant Traditional Chinese Medicine Therapy on Long-Term Survival in Patients with Hepatocellular Carcinoma</article-title>. <source>Phytomedicine</source> <volume>62</volume>, <fpage>152930</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2019.152930</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Puerarin Suppresses LPS-Induced Breast Cancer Cell Migration, Invasion and Adhesion by Blockage NF-&#x39a;b and Erk Pathway</article-title>. <source>Biomed. Pharmacother.</source> <volume>92</volume>, <fpage>429</fpage>&#x2013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2017.05.102</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y. Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y. P.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>The Natural Compound Magnolol Inhibits Invasion and Exhibits Potential in Human Breast Cancer Therapy</article-title>. <source>Sci. Rep.</source> <volume>3</volume>, <fpage>3098</fpage>. <pub-id pub-id-type="doi">10.1038/srep03098</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>439</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.00439</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dushyanthen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Beavis</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Salgado</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Denkert</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Savas</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation between MEK and PD-1/pd-L1 Immune Checkpoint Inhibitors</article-title>. <source>Clin. Cancer Res.</source> <volume>25</volume> (<issue>4</issue>), <fpage>1437</fpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-15-1125</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wink</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Lobeline, a Piperidine Alkaloid from Lobelia Can Reverse P-Gp Dependent Multidrug Resistance in Tumor Cells</article-title>. <source>Phytomedicine</source> <volume>15</volume> (<issue>9</issue>), <fpage>754</fpage>&#x2013;<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2007.11.028</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maleki</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Crespo</surname>
<given-names>J.&#x20;F.</given-names>
</name>
<name>
<surname>Cabanillas</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Anti-inflammatory Effects of Flavonoids</article-title>. <source>Food Chem.</source> <volume>299</volume>, <fpage>125124</fpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mittendorf</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Philips</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Meric-Bernstam</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Harrington</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>PD-L1 Expression in Triple-Negative Breast Cancer</article-title>. <source>Cancer Immunol. Res.</source> <volume>2</volume> (<issue>4</issue>), <fpage>361</fpage>&#x2013;<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1158/2326-6066.CIR-13-0127</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y. P.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Effectiveness and Safety of Chemotherapy Combined with Cytokine-Induced Killer Cell/dendritic Cell-Cytokine-Induced Killer Cell Therapy for Treatment of Gastric Cancer in China: A Systematic Review and Meta-Analysis</article-title>. <source>Cytotherapy</source> <volume>18</volume> (<issue>9</issue>), <fpage>1162</fpage>&#x2013;<lpage>1177</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcyt.2016.05.015</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oh</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The Standardized Korean Red Ginseng Extract and its Ingredient Ginsenoside Rg3 Inhibit Manifestation of Breast Cancer Stem Cell-like Properties through Modulation of Self-Renewal Signaling</article-title>. <source>J.&#x20;Ginseng Res.</source> <volume>43</volume> (<issue>3</issue>), <fpage>421</fpage>&#x2013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1016/j.jgr.2018.05.004</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Estrogen Receptor-&#x391;36 Is Involved in Epigallocatechin-3-Gallate Induced Growth Inhibition of ER-Negative Breast Cancer Stem/progenitor Cells</article-title>. <source>J.&#x20;Pharmacol. Sci.</source> <volume>130</volume> (<issue>2</issue>), <fpage>85</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphs.2015.12.003</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer</article-title>. <source>Front. Pharmacol.</source> <volume>10</volume>, <fpage>590</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2019.00590</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pantelidou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sonzogni</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>De Oliveria Taveira</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Kothari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>PARP Inhibitor Efficacy Depends on CD8&#x2b; T-Cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer</article-title>. <source>Cancer Discov.</source> <volume>9</volume> (<issue>6</issue>), <fpage>722</fpage>&#x2013;<lpage>737</lpage>. <pub-id pub-id-type="doi">10.1158/2159-8290</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pareja</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reis-Filho</surname>
<given-names>J.&#x20;S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Triple-negative Breast Cancers - a Panoply of Cancer Types</article-title>. <source>Nat. Rev. Clin. Oncol.</source> <volume>15</volume> (<issue>6</issue>), <fpage>347</fpage>&#x2013;<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1038/s41571-018-0001-7</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J.&#x20;Y.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>T. M.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Down-regulation of C-Src/EGFR-Mediated Signaling Activation Is Involved in the Honokiol-Induced Cell Cycle Arrest and Apoptosis in MDA-MB-231 Human Breast Cancer Cells</article-title>. <source>Cancer Lett.</source> <volume>277</volume> (<issue>2</issue>), <fpage>133</fpage>&#x2013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2008.11.029</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pettitt</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Frankum</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Punta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lise</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Clinical BRCA1/2 Reversion Analysis Identifies Hotspot Mutations and Predicted Neoantigens Associated with Therapy Resistance</article-title>. <source>Cancer Discov.</source> <volume>142</volume> (<issue>6</issue>), <fpage>2699</fpage>&#x2013;<lpage>2703</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.9b10510</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramamoorthy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dandawate</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Anant</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells</article-title>. <source>Biomedicines</source> <volume>9</volume> (<issue>5</issue>), <fpage>482</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines9050482</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Antiproliferative Activity of Combined Biochanin A and Ginsenoside Rh&#x2082; on MDA-MB-231 and MCF-7 Human Breast Cancer Cells</article-title>. <source>Molecules</source> <volume>23</volume> (<issue>11</issue>), <fpage>2908</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23112908</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Benefit in Patients with PD-L1-Positive TNBC</article-title>. <source>Nat. Rev. Clin. Oncol.</source> <volume>16</volume> (<issue>1</issue>), <fpage>6</fpage>. <pub-id pub-id-type="doi">10.1038/s41571-018-0127-7</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Sinomenine Reduces Growth and Metastasis of Breast Cancer Cells and Improves the Survival of Tumor-Bearing Mice through Suppressing the SHh Pathway</article-title>. <source>Biomed. Pharmacother.</source> <volume>98</volume>, <fpage>687</fpage>&#x2013;<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2017.12.065</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tachikawa</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.&#x20;J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Dendritic Cells Maturation Promoted by M1 and M4, End Products of Steroidal Ginseng Saponins Metabolized in Digestive Tracts, Drive a Potent Th1 Polarization</article-title>. <source>Biochem. Pharmacol.</source> <volume>68</volume> (<issue>3</issue>), <fpage>441</fpage>&#x2013;<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2004.04.015</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Peimine Inhibits the Growth and Motility of Prostate Cancer Cells and Induces Apoptosis by Disruption of Intracellular Calcium Homeostasis through Ca2&#x2b;/CaMKII/JNK Pathway</article-title>. <source>J.&#x20;Cel Biochem</source> <volume>121</volume> (<issue>1</issue>), <fpage>81</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.28870</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tegowski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baldwin</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Noncanonical NF-&#x39a;b in Cancer</article-title>. <source>Biomedicines</source> <volume>6</volume> (<issue>2</issue>), <fpage>66</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines6020066</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.&#x20;Y.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>K. L.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells</article-title>. <source>Evid. Based Complement. Alternat Med.</source> <volume>2013</volume>, <fpage>421051</fpage>. <pub-id pub-id-type="doi">10.1155/2013/421051</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ullmannova</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Popescu</surname>
<given-names>N. C.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Inhibition of Cell Proliferation, Induction of Apoptosis, Reactivation of DLC1, and Modulation of Other Gene Expression by Dietary Flavone in Breast Cancer Cell Lines</article-title>. <source>Cancer Detect. Prev.</source> <volume>31</volume> (<issue>2</issue>), <fpage>110</fpage>&#x2013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.cdp.2007.02.005</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Inhibition of Growth and Metastasis of Triple-Negative Breast Cancer Targeted by Traditional Chinese Medicine Tubeimu in Orthotopic Mice Models</article-title>. <source>Chin. J.&#x20;Cancer Res.</source> <volume>30</volume> (<issue>1</issue>), <fpage>112</fpage>&#x2013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.21147/j.issn.1000-9604.2018.01.12</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Ginsenoside Panaxatriol Reverses TNBC Paclitaxel Resistance by Inhibiting the IRAK1/NF-&#x39a;b and ERK Pathways</article-title>. <source>PeerJ</source> <volume>8</volume>, <fpage>e9281</fpage>. <pub-id pub-id-type="doi">10.7717/peerj.9281</pub-id> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Targeted Regulation of Rell2 by microRNA-18a Is Implicated in the Anti-metastatic Effect of Polyphyllin VI in Breast Cancer Cells</article-title>. <source>Eur. J.&#x20;Pharmacol.</source> <volume>851</volume>, <fpage>161</fpage>&#x2013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2019.02.041</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Gambogic Acid Increases the Sensitivity to Paclitaxel in Drug-Resistant Triple-Negative Breast Cancer via the SHH Signaling Pathway</article-title>. <source>Mol. Med. Rep.</source> <volume>20</volume> (<issue>5</issue>), <fpage>4515</fpage>&#x2013;<lpage>4522</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2019.10697</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Antitumor Effects of Immunity-Enhancing Traditional Chinese Medicine</article-title>. <source>Biomed. Pharmacother.</source> <volume>121</volume>, <fpage>109570</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2019.109570</pub-id> </citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wild</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fritz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schuler</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>T. K.</given-names>
</name>
<name>
<surname>Lotfi</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>HMGB1 Conveys Immunosuppressive Characteristics on Regulatory and Conventional T&#x20;Cells</article-title>. <source>Int. Immunol.</source> <volume>24</volume> (<issue>8</issue>), <fpage>485</fpage>&#x2013;<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/dxs051</pub-id> </citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Nano-puerarin Regulates Tumor Microenvironment and Facilitates Chemo- and Immunotherapy in Murine Triple Negative Breast Cancer Model</article-title>. <source>Biomaterials</source> <volume>235</volume>, <fpage>119769</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.119769</pub-id> </citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Berberine Inhibits NLRP3 Inflammasome Pathway in Human Triple-Negative Breast Cancer MDA-MB-231 Cell</article-title>. <source>BMC Complement. Altern. Med.</source> <volume>19</volume> (<issue>1</issue>), <fpage>216</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-019-2615-4</pub-id> </citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Honokiol Antagonizes Doxorubicin Resistance in Human Breast Cancer via miR-188-5p/FBXW7/c-Myc Pathway</article-title>. <source>Cancer Chemother. Pharmacol.</source> <volume>87</volume> (<issue>5</issue>), <fpage>647</fpage>&#x2013;<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1007/s00280-021-04238-w</pub-id> </citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname>
<given-names>Y. D.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. S.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Toll-like Receptor 4-dependent Activation of Macrophages by Polysaccharide Isolated from the Radix of Platycodon Grandiflorum</article-title>. <source>Int. Immunopharmacol</source> <volume>3</volume> (<issue>13-14</issue>), <fpage>1873</fpage>&#x2013;<lpage>1882</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2003.09.005</pub-id> </citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>K. D.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>F. G.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women with Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial</article-title>. <source>JAMA Oncol.</source> <volume>6</volume> (<issue>9</issue>), <fpage>1390</fpage>&#x2013;<lpage>1396</lpage>. <pub-id pub-id-type="doi">10.1001/jamaoncol.2020.2965</pub-id> </citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>SENP3 Maintains the Stability and Function of Regulatory T&#x20;Cells via BACH2 deSUMOylation</article-title>. <source>Nat. Commun.</source> <volume>89</volume> (<issue>1</issue>), <fpage>3157</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-05676-6</pub-id> </citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Ginsenoside Rg3 Promotes Cytotoxicity of Paclitaxel through Inhibiting NF-&#x39a;b Signaling and Regulating Bax/Bcl-2 Expression on Triple-Negative Breast Cancer</article-title>. <source>Biomed. Pharmacother.</source> <volume>89</volume>, <fpage>227</fpage>&#x2013;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2017.02.038</pub-id> </citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yumimoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Akiyoshi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ueo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sagara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Onoyama</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ueo</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>F-box Protein FBXW7 Inhibits Cancer Metastasis in a Non-cell-autonomous Manner</article-title>. <source>J.&#x20;Clin. Invest.</source> <volume>125</volume> (<issue>2</issue>), <fpage>621</fpage>&#x2013;<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1172/JCI78782</pub-id> </citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and P38 MAPK Signaling Pathways</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>601468</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.601468</pub-id> </citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Induced Expression of PD-1, a Novel Member of the Immunoglobulin Gene Superfamily, upon Programmed Cell Death</article-title>. <source>Front. Immunol.</source> <volume>11</volume>, <fpage>609705</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2020.609705</pub-id> </citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H. L.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>2-((1-Phenyl-1H-1,2,3-triazol-4-yl) Methyl)-2-Azabicyclo [3.2.1] Octan-3-One Derivatives: Simplification and Modification of Aconitine Scaffold for the Discovery of Novel Anticancer Agents</article-title>. <source>Eur. J.&#x20;Med. Chem.</source> <volume>210</volume>, <fpage>112988</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2020.112988</pub-id> </citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Sinomenine Inhibits Osteolysis in Breast Cancer by Reducing IL-8/CXCR1 and C-Fos/NFATc1 Signaling</article-title>. <source>Pharmacol. Res.</source> <volume>142</volume>, <fpage>140</fpage>&#x2013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2019.02.015</pub-id> </citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Triptolide Interferes with XRCC1/PARP1-Mediated DNA Repair and Confers Sensitization of Triple-Negative Breast Cancer Cells to Cisplatin</article-title>. <source>Biomed. Pharmacother.</source> <volume>109</volume>, <fpage>1541</fpage>&#x2013;<lpage>1546</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2018.11.008</pub-id> </citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Berberine Inhibits MDA-MB-231 Cells by Attenuating Their Inflammatory Responses</article-title>. <source>Biomed. Res. Int.</source> <volume>2020</volume>, <fpage>3617514</fpage>. <pub-id pub-id-type="doi">10.1155/2020/3617514</pub-id> </citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Berberine Activates Caspase-9/cytochrome C-Mediated Apoptosis to Suppress Triple-Negative Breast Cancer Cells <italic>In Vitro</italic> and <italic>In Vivo</italic>
</article-title>. <source>Biomed. Pharmacother.</source> <volume>95</volume>, <fpage>18</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2017.08.045</pub-id> </citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kryczek</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Aguilar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The Ubiquitin Ligase MDM2 Sustains STAT5 Stability to Control T Cell-Mediated Antitumor Immunity</article-title>. <source>Nat. Immunol.</source> <volume>22</volume> (<issue>4</issue>), <fpage>460</fpage>&#x2013;<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1038/s41590-021-00888-3</pub-id> </citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Ophiopogonin D Suppresses TGF-&#x392;1-Mediated Metastatic Behavior of MDA-MB-231 Breast Carcinoma Cells via Regulating ITGB1/FAK/Src/AKT/&#x3b2;-catenin/MMP-9 Signaling axis</article-title>. <source>Toxicol. Vitro</source> <volume>69</volume>, <fpage>104973</fpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2020.104973</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>